普萘洛尔缩短分娩时间:随机对照试验的荟萃分析
本荟萃分析纳入5项随机对照试验共660例患者,评估普萘洛尔对引产或催产患者分娩时间的影响。汇总结论显示,与安慰剂相比,普萘洛尔未显著缩短分娩时间(均差-4.33分钟,95%CI -22.48至13.83),且未增加产后出血、输血、剖宫产或新生儿重症监护病房入院风险。
要点
- 引产患者中普萘洛尔组分娩时间828±324分钟 vs 安慰剂组858±318分钟(P=.48),无显著差异。
- 催产患者中普萘洛尔未显著缩短分娩时间(均差-2.98分钟,95%CI -21.6至15.6)。
- 汇总分析未发现普萘洛尔增加产后出血、输血、剖宫产或新生儿重症监护病房入院风险。
核心结论
- 引产和催产期间使用普萘洛尔未显著缩短分娩时间。
研究设计与样本
- 随机对照试验的荟萃分析,检索PubMed、Scopus、Cochrane Library、ClinicalTrials.gov和CINAHL(EBSCO)数据库,从建库至2023年12月,纳入5项随机对照试验共660例患者。
主要发现
- 1项研究比较引产患者中普萘洛尔与安慰剂,分娩时间828±324分钟 vs 858±318分钟(P=.48),未显示显著缩短。
- 4项研究评估催产患者中普萘洛尔的效果,分娩时间均差-2.98分钟(95%CI -21.6至15.6),无显著缩短。
- 汇总分析显示普萘洛尔与安慰剂相比,分娩时间均差-4.33分钟(95%CI -22.48至13.83),无显著差异。
- 荟萃分析未发现普萘洛尔增加产后出血、输血、剖宫产率或新生儿重症监护病房入院风险。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: This study aimed to assess the effect of propranolol on the time to delivery among patients undergoing induction or augmentation of labor. DATA SOURCES: PubMed, Scopus, Cochrane Library, ClinicalTrials.gov, and CINAHL (EBSCO) databases were searched from inception to December 2023. STUDY ELIGIBILITY CRITERIA: Randomized controlled trials that examined the effect of propranolol on the time to delivery among patients undergoing induction or augmentation of labor were included. Randomized controlled trials that included stillbirth before randomization, nonrandomized trials, observational, cohort, case-control, or studies in which the control group included an intervention other than standard care were excluded. METHODS: The primary outcome was time to delivery after the administration of propranolol among patients undergoing induction or augmentation of labor. The summary measures were reported as summary mean difference or relative risk with 95% confidence interval. RESULTS: A total of 5 randomized controlled trials involving 660 patients were included in this meta-analysis. 1 study investigated the effect of propranolol compared with that of placebo among patients undergoing induction of labor and did not demonstrate a significant decrease in the time to delivery (828±324 minutes in the propranolol group vs 858±318 minutes in the placebo group; P=.48). In addition, 4 studies investigated the effect of propranolol among patients undergoing augmentation of labor and showed no significant decrease in the time to delivery (mean difference, -2.98 minutes [95% confidence interval, -21.6 to 15.6]). Our pooled analysis demonstrated that the use of propranolol in the induction and augmentation of labor was not associated with a decrease in the time to delivery from the administration of propranolol compared with that of placebo (mean difference, -4.33 minutes [95% confidence interval, -22.48 to 13.83]). The meta-analysis found no increased risk of postpartum hemorrhage, blood transfusion, cesarean delivery rate, or neonatal intensive care unit admission with the use of propranolol during labor. CONCLUSION: The use of propranolol during induction and augmentation of labor did not significantly decrease the time to delivery.
引用
- Biswas S, Toro M, Horgan R, et al. Propranolol to decrease time to delivery: a meta-analysis of randomized controlled trials. Am J Obstet Gynecol MFM. 2025. PMID: 40414426. doi:10.1016/j.ajogmf.2025.101705
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。